Navigation Links
ReBuilder (RBRM) Files Complaints Against Stock Traders
Date:2/23/2012

CHARLES TOWN, W. Va., Feb. 23, 2012 /PRNewswire/ -- The management of ReBuilder Medical Technologies, Inc.  (Pink Sheets: RBRM) announces it has filed complaints with the U.S. Securities Exchange Commission and the The Financial Industry Regulatory Authority (FINRA) alleging certain traders of the Company shares may have engaged in the unlawful and unethical sale and trading of the Company's shares.   The firmed has hired a forensic expert to audit all stock certificates and stock trading that has occurred over the last eight (8) months.  Further information can be obtained by contacting the Company at 304-725-2202.

The company has recently experienced unexplained dips in its share price, and has uncovered instances of independent third party traders who have promised shares or sold shares, never delivered them, and refused to return their customer's money.

The company has discovered several other companies that have fallen prey to these unscrupulous independent traders.  Evidently, the traders convince their pool of customers to sell shares from prior sales and move the money to their new mark, buying on the open market, thus increasing the price, promising to give them additional shares as a reward.  The original company's shares drop when the traders sell into the market, and the scheme is repeated over and over again. 

Similar to a Ponzie scheme, these traders sometimes extort shares from companies for "awareness programs" and pay off a few of the investors who complain.  Other investors, embarrassed by being taken in when the stock price inevitably drops, just give up.

The end result for a company is a sudden increase in volume and price, followed by a drop to an even lower level than it was, and the company itself has no idea of what is happening in the background and has to deal with its original core investor's ire, and can appear incompetent.  This takes time from day to day management and makes it harder to attract new, legitimate, long term investors.

RBRM is in the DME (durable medical equipment) business of submitting claims on behalf of customers who purchase the ReBuilder device for the pain of neuropathy, peripheral neuropathy, diabetic neuropathy, and chemo induced neuropathy.  The company buys its ReBuilders directly from the manufacturer, ReBuilder Medical Inc. (www.rebuildermedical.com).

ReBuilder Medical Inc. is developing several other medical devices that RBRM is negotiating to sell to its neuropathy customers when approved by the FDA.  One of the more interesting devices is one that makes it easy and painless for the nurse to draw blood. For a 2 minute video demonstration, see  www.veinappear.com.


'/>"/>
SOURCE ReBuilder Medical Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ReBuilder Medical Technologies, Inc. Hiring! Increases Staff by 40%
2. ReBuilder Medical Technologies, Inc. Reports LOI With National DME Distributor
3. Acella Pharmaceuticals, LLC, Files Abbreviated New Drug Application (ANDA) With the U.S. Food & Drug Administration
4. Natural Alternatives International, Inc. Files Patent Infringement Claim Against DNP International Co., Inc.
5. Department of Justice files consent decree of permanent injunction against Ranbaxy
6. Oramed Pharmaceuticals Files US Patent Application for Combination Oral Treatment of Diabetes
7. Intellect Neurosciences Files Appeal in Europe in Response to Opposition Proceedings Instituted by Elan Pharmaceuticals and Wyeth/Pfizer
8. Amherst-Based Pharmaceutical Company Files Federal Lawsuit Accusing Competitor of False Claims Regarding the Efficacy of Infasurf®, its Life-Saving Respiratory Drug for Premature Infants
9. Alcohol Monitoring Systems Files Appeal With Federal Circuit Court in Patent Suit
10. Pinnacle Biologics Files for Orphan Drug Designation for PHOTOFRIN® in the Treatment of Patients with Malignant Mesothelioma.
11. Par Pharmaceutical Files Declaratory Judgment to Protect First Amendment Rights to Disseminate Truthful Information Regarding Megace® ES
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... YORK , Feb. 24, 2017 ... Monteverde & Associates PC , a boutique securities firm ... New York City , announces that a class ... Massachusetts  against Inotek Pharmaceuticals Corporation ... of the Company,s securities between July 23, 2015 and December ...
(Date:2/24/2017)... ITL Limited, ( ASX: ITD ), ... für das zum 31. Dezember 2016 endende Halbjahr ... vorlegen zu können. Eine vollständige Präsentation „Ergebnisse von ... Sie hier . Glanzpunkte ... 2015: 1,04 Millionen USD; +104 %) Gewinn je ...
(Date:2/24/2017)... YORK , Feb. 23, 2017  This report ... Thousand by the following Products: Intermediates, ... in the report include Pharmaceuticals, and Agrochemicals. The report ... Japan , Europe , and ... for the period 2015 through 2022. Also, a six-year ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... February 24, 2017 , ... The International Association of Eating Disorders Professionals (iaedp) ... You See” body image mannequin art competition. Selected from 15 submissions from around the ... revealed at the 31st annual iaedp Symposium, March 22 – 26 in Las Vegas. ...
(Date:2/24/2017)... ... February 24, 2017 , ... Castle Farms, the celebrated ... Giveaway, with the winning couple announced on Feb. 14, 2017, on Facebook. The ... local vendors: A Matter of Taste, Ryan Rousseau Enterprises, A Touch of Spring ...
(Date:2/23/2017)... ... 23, 2017 , ... Rare Disease Report®, which is the ... Rare Disease Day events, hosted by the Rare Disease Legislative Advocates (RDLA) on ... weekly e-newsletter and quarterly publication, will be conducting interviews with patients and advocates ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... for the National Institute for Health and Care Excellence (NICE) framework. ... the National Health Service (NHS) to search, order and purchase medical and healthcare-related ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... Phoenix, announced today that it will soon begin franchising throughout the U.S. starting ... mission to help bring the practice of meditation mainstream. Current Meditation will be ...
Breaking Medicine News(10 mins):